To this end, we measured the CTC levels in blood and mRNA expression levels of CCNI, EGFR, FGF19, and FRS2 in saliva of 140 NSCLC patients and 140 healthy controls, respectively. This evidence concerns the gene FGF19 and non-small cell lung carcinoma.